Upside – $KOD +60% (pivotal Phase 3 DAYBREAK wet-AMD trial met its primary noninferiority endpoints, with most patients reaching a 24-week dosing interval) – $ARAY +39% (agrees to explore integrating Samsung NeuroLogica volumetric imaging technology with the CyberKnife platform) – $MEDS +28% (launches a GLP-1 care app offering telehealth consultations and access to branded medications) …
Read in context ›Maris-Tech Ltd. Stock (MTEK)
Track Maris-Tech Ltd. stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
MTEK
Maris-Tech Ltd.
technology
$1.02
▼ -2.34 (-68.02%) past year
Market Cap
$11.56M
P/E Ratio
—
1Y Return
-68.02%
EPS (TTM)
-$0.67
Read the latest TheStreet Pro articles mentioning Maris-Tech Ltd., including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning MTEK yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning